Evidence map›Paper›PMID 26057975›Full record

ArticleNature biotechnology2015

Access to new technologies in multipatented vaccines: challenges for Brazil.

Cristina Possas, Adelaide Maria de Souza Antunes, Flavia Maria Lins Mendes, Suzanne de Oliveira Rodrigues Schumacher, Reinaldo Menezes Martins, Akira Homma

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Reply to the Letter to the Editors by Beirão.Cadernos de saude publica · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cristina Possas1] Bio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil; [2] Evandro Chagas National Institute of Infectology, FIOCRUZ, Rio de Janeiro, Brazil; and.
Adelaide Maria de Souza Antunes1] School of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; [2] National Institute of Industrial Property, Rio de Janeiro, Brazil.
Flavia Maria Lins MendesSchool of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil;
Suzanne de Oliveira Rodrigues SchumacherSchool of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil;
Reinaldo Menezes MartinsBio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil;
Akira HommaBio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil;

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Intellectual PropertyVaccinesBrazilHumansPatents as TopicPublic HealthVaccines

Identifiers

PMID26057975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.